Number of active disease-modifying Alzheimer's drug trials globally in 2019, by phase

Total number of currently active global novel disease-modifying clinical trials for Alzheimer's disease drugs in early 2019, by phase*

Show detailed source information?
Register for free
Already a member?
Log in

Use Ask Statista Research Service

Release date

May 2019



Survey time period

February 28, 2019

Supplementary notes

* Twelve programs listed as “Ex-US” in the Biomedtracker database are included here by phase based on independent research of company websites. This “Ex-US” listing implies the companies have not yet intended to seek FDA approval. No NDA/BLA filings were active for Alzheimer’s Disease as of February 28, 2019. Only novel approaches with disease modifying potential in Alzheimer’s disease are shown.

Citation formats
Statista Accounts: Access All Statistics. Starting from $2,388 USD / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$199 USD / Month *
Professional Account
Full access

Business Solutions including all features.

* Prices do not include sales tax.

Statistics on " Dementia and Alzheimer's disease in Europe "

Other statistics that may interest you Dementia and Alzheimer's disease in Europe

World overview


European focus


Mortality and morbidity


Situation in specific countries


Policies directed towards dementia


Further related statistics


Further Content: You might find this interesting as well


Statista Accounts: Access All Statistics. Starting from $2,388 USD / Year
Learn more about how Statista can support your business.